Belkyra is an aesthetic procedure that utilises a safe injectable treatment to reduce submental fullness (more commonly known as a “double chin”). The procedure is completely non-invasive – redefining the jawline with no surgery or incision required – and is clinically proven to reduce the appearance of the double chin.
The Belkyra injectable works by destroying the cell membranes of the fat cells that cause the double chin. The glycerol and fatty acids contained within the cell are then released into the surrounding subcutaneous space before being naturally absorbed by and eliminated from the body.
Typically, a Belkyra procedure at Eastern Plastic Surgery will be between 30-45 minutes long. A minimum of two treatments will be required, while some patients may require up to four sessions.
Lipolysis is a surgical procedure requiring incision and sutures, while Belkyra is more suitable for those who wish to treat the double chin subtly and non-invasively. The Belkyra treatment destroys the fat cells in the double chin area, as opposed to lipolysis in which the fat is actually aspirated out and removed.
The Belkyra treatment is customized to suit each patient’s individual circumstances. However, pregnant or breastfeeding women, patients who have heart or liver problems and patients who have an excess amount of skin on their necks are not suitable candidates for Belkyra.
Most Belkyra patients can expect to see a visible reduction to their double chin after two sessions. As with any cosmetic injectable procedure, it is normal for patients to experience some discomfort and a slight bruising sensation following the treatments. There may be some pain, redness and at least some mild swelling, indicating that the product is working. These side effects can be managed with cold packs and/or oral analgesics as required.